Henrik Zetterberg | |
---|---|
Born | 1973 (age 50–51) |
Alma mater | University of Gothenburg |
Known for | Alzheimer research |
Scientific career | |
Fields | Neurochemistry |
Institutions | University of Gothenburg and University College London |
Doctoral advisor | Lars Rymo [1] |
Other academic advisors | Dennis J. Selkoe |
Henrik Zetterberg (born 1973) [2] is a Swedish professor of neurochemistry at the University of Gothenburg, where he is the Head of the Department of Neurochemical Pathophysiology and Diagnostics. [3] He is also the leader of the Fluid biomarkers for neurodegenerative diseases group at University College London. The groups work on developing early tests for dementia. [4]
Zetterberg was born [2] and brought up in the Gothenburg archipelago, Sweden. [1] He completed his doctoral thesis in 2003 on the subject of the Epstein–Barr virus. [5] He performed postdoctoral research at Harvard using zebrafish as a model for alzheimer's disease. [6] [1] Zetterberg has worked together with Kaj Blennow, whom he met during his PhD, on many projects including coleading the Clinical Neurochemistry Laboratory together with him. [1]
His research includes the development of methods for early diagnostics for frontotemporal dementia through the use of Biomarkers, [7] In 2020, a team of scientists led by Zetterberg published results regarding a new diagnostic for Alzheimer's disease based on protein concentrations in cerebrospinal fluid, which is a colorless fluid surrounding the brain and spinal cord. The test was reported to have an accuracy of around 90% and could detect the disease about two decades before significant symptoms were present. [8]